DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群
Pyogenic arthritis
Clinical trials
/
Disease details
臨床試験数
:
24
/
薬物数
:
30
- (
DrugBank
:
12
) /
標的遺伝子数
:
15
-
標的パスウェイ数
:
105
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03137160
(
ClinicalTrials.gov
)
May 4, 2017
27/4/2017
An Open-Label, Proof-of-Concept Study of
Ixekizumab
in the Treatment of Pyoderma Gangrenosum
An Open-Label, Proof-of-Concept Study of
Ixekizumab
in the Treatment of Pyoderma Gangrenosum
Pyoderma Gangrenosum
Biological:
Ixekizumab
Ohio State University
Eli Lilly and Company
Completed
18 Years
N/A
All
5
Phase 2
United States